突变的p53调节了复杂的三维环境中的癌细胞入侵,通过依赖于美酸途径的Rho/ROCK信号传递来调节
Asja Guzman1, Tatsuya Kawase2, Alexander J Devanny3
1Department of Biological Sciences, Columbia University, New York, NY 10027.
概括
突变TP53蛋白通过提高细胞收缩性和细胞外矩阵重塑来增强癌细胞入侵. 这种功能增长与代谢途径有关,并受到瘤微环境的影响.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 某些TP53突变为p53赋予了新型的功能增益 (GOF) 活动,影响了癌症的进展.
- 突变p53GOF的概念面临着严格的审查,需要进一步调查.
研究的目的:
- 为了证明突变的p53刺激癌细胞入侵.
- 阐明突变p53介导的入侵背后的机制.
- 探索细胞-ECM相互作用在调节突变p53GOF活动中的作用.
主要方法:
- 利用各种策略来改变细胞系中的突变p53状态.
- 在三维环境中评估癌细胞的入侵.
- 研究了RhoA/ROCK信号传递,氨酸通路和细胞-ECM相互作用.
主要成果:
- 突变p53被证明可以在3D中刺激癌细胞入侵.
- 突变的p53增强了RhoA/ROCK依赖的细胞收缩性和ECM重组.
- 梅瓦诺酸路径活性,特别是IDI-1,调解RhoA依赖的侵袭性作用.
- 突变p53的侵袭增强效应是由ECM生物力学特性和细胞-ECM相互作用调节的.
结论:
- 突变p53的代谢GOF活性与一个上下文依赖的侵入性细胞表型有关.
- 这些发现突出了一个细胞独立的调节层,涉及动态细胞-ECM相互作用.
- 这项研究提供了对突变p53GOF及其在癌症进展中的作用的机制性见解.
相关概念视频
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Small GTPases - Ras and Rho
5.1K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.1K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K


